References
Streisand JB, Varvel JR, Stanski DR, et al. Absorption and bio-availability of oral transmucosal fentanyl citrate. Anesthesiology 1991; 75: 223–9
Varvel JR, Shafer SL, Hwang SS, et al. Absorption characteristics of transdermally administered fentanyl. Anesthesiology 1989; 70: 928–34
Streisand JB, Rosenberg JA, Ashburn MA, et al. Oral transmucosal fentanyl citrate: repeated dose pharmacokinetics [abstract]. Anesthesiology 1993; 79: A369
Preston R, Csontos ER, East KA, et al. Plasma fentanyl concentrations after oral transmucosal fentanyl citrate: children versus adults [abstract]. Anesthesiology 1993; 79: A370
Feld LH, Champeau MW, van Steennis CA, et al. Preanesthetic medication in children: a comparison of oral transmucosal fentanyl citrate versus placebo. Anesthesiology 1989; 71: 374–7
Friesen RH, Lockhart CH. Oral transmucosal fentanyl citrate for preanesthetic medication of pediatric day surgery patients with and without droperidol as a prophylactic anti-emetic. Anesthesiology 1992; 76: 46–51
Nelson PS, Streisand JB, Mulder SM, et al. Comparison of oral transmucosal fentanyl citrate and an oral solution of meperidine, diazepam, and atropine for premedication in children. Anesthesiology 1989; 70: 616–21
Stanley TH, Hague BH, Mock DL, et al. Oral transmucosal fentanyl citrate (lollipop) premedication in human volunteers. AnesthAnalg 1989; 69: 21–7
Streisand JB, Stanley TH, Hague B, et al. Oral transmucosal fentanyl citrate premedication in children. Anesth Analg 1989; 69: 28–34
Ashburn MA, Streisand JB, Tarver SD, et al. Oral transmucosal fentanyl citrate for premedication in paediatric outpatients. Can J Anaesth 1990; 37: 857–66
Stanley TH, Leiman BC, Rawal N, et al. The effects of oral transmucosal fentanyl citrate premedication on preoperative behavioral responses and gastric volume and acidity in children. Anesth Analg 1989; 69: 328–35
Schechter NL, Weisman SJ, Rosenblum M, et al. Sedation for painful procedures in children with cancer using the fentanyl lollipop: a preliminary report. In: Tyler D, Krane E, editors. Advances in pain research therapy. New York: Raven Press, 1990:209–13
Lind GH, Marcus MA, Mears SL, et al. Oral transmucosal fentanyl citrate for analgesia and sedation in the emergency department. Ann Emerg Med 1991; 20: 1117–20
Ashburn MA, Lind GH, Gillie MH, et al. Oral transmucosal fentanyl citrate (OTFC) for the treatment of postoperative pain. Anesth Analg 1993; 76: 402–16
Love G, Ashburn MA, Stanley TH. Oral transmucosal fentanyl citrate (OTFC) for the treatment of acute pain in adults. 7th World Congress on Pain, Aug 22–27 1993, Paris. Seattle: International Association for the Study of Pain, 1993: 386–7
Fine PF, Marcus M, De Boer AJ, et al. An open label study of oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough cancer pain. Pain 1991; 45: 149–53
Ashburn MA, Fine PG, Stanley TH. Oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: a case report. Anesthesiology 1989; 71: 615–7
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ashburn, M.A., Streisand, J.B. Oral Transmucosal Fentanyl. Drug-Safety 11, 295–300 (1994). https://doi.org/10.2165/00002018-199411050-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-199411050-00001